The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 578-585

  Bristow, Linda J ^a   Flatman, Karen L ^a   Hutson, Peter H ^a   Kulagowski, Janusz J ^a   Leeson, Paul D ^a   Young, Lisa ^a   Tricklebank, Mark D ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 7 CHLORO 4 HYDROXY 3 (2 PHENOXYPHENYL) 2(H) QUINOLONE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; AMPHETAMINE; APOMORPHINE; CLOZAPINE; GLYCINE RECEPTOR ANTAGONIST; HALOPERIDOL; L 701357; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG SELECTIVITY; HYPERACTIVITY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTYPED BEHAVIOR;

EID: 0030431439     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. ANDEN, N. E.: Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs J. Pharm. Pharmacol. 24: 905-906, 1972.
2. BALDESSARINI, R. J.: Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu. Rev. Neurosci. 3: 23-41, 1980.
3. BEN-JONATHAN, N.: Dopamine: A prolactin-inhibiting hormone. Endocr. Rev. 6: 564-589, 1985.
4. BOLDRY, R. C. AND URETSKY, N. J.: The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens. Neuropharmacology 27: 569-577, 1988.
5. BOWERS, M. B. AND HOFFMAN, F. J.: Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine. Psychopharmacology 84: 136-137, 1984.
6. BRISTOW, L. J., HUTSON, P. H., THORN, L. AND TRICKLEBANK, M. D.: The glycine/ NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br. J. Pharmacol. 108: 1156-1163, 1993.
7. BRISTOW, L J., LANDON, L , SAYWELL, K. L. AND TRICKLEBANK, M. D.: The glycine/ NMDA receptor antagonist, L-701,324, reverses isolation-induced deficits in prepulse inhibition in the rat. Psychopharmacology 118: 230-232, 1995.
8. BRISTOW, L. J., THORN, L., TRICKLEBANK, M. D. AND HUTSON, P. H : Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice. Eur J. Pharmacol. 264: 353-359, 1994.
9. BURKI, H. R., SAYERS, A. C., RUCH, W. AND ASPER, H.: Effects of clozapine and other dibenzoepines on central dopaminergic and cholinergic systems. Arzneim-Forsch. 27: 1561-1565, 1977.
10. CARLSSON, M. AND CARLSSON, A.: Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13: 272-276, 1990.
11. CHERGUI, K., CHARLETY, P. J., AKAOKA, H., SAUNIER, C. F., BRUNET, J. L., BUDA, M., SVENSSON, T. H. AND CHOUVET, G.: Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurones in vivo. Eur. J. Neurosci 5: 137-144, 1993.
12. CHIODO, L. A. AND BUNNEY, B. S.: Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurones. J. Neurosci. 3: 1607-1619, 1983.
13. CLEMENS, J A., SMALSTIG, E. B. AND SAWYER, B. D.: Antipsychotic drugs stimulate prolactin release. Psychopharmacologia (Berl) 40: 123-127, 1974.
14. CONTRERAS, P. C.: D-serine antagonised phencyclidine and MK-801-induced stereotyped behaviour and ataxia. Neuropharmacology 29: 291-293, 1990.
15. COSTALL, B. AND NAYLOR, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneim-Forsch. 23: 674-683, 1973.
16. DEUTCH, A. Y., TAM, S. Y., FREEMAN, A. S., BOWERS, M. B. AND ROTH, R. H.: Mesolimbic and mesocortical dopamine activation induced by phencyclidine: Contrasting pattern to striatal response. Eur. J. Pharmacol. 134: 257-264, 1987.
17. DEUTSCH, S. I., MASTROPAOLO, J., SCHWARTZ, B. L., ROSSE, R. B. AND MORIHISA, J. M.: A glutamatergic hypothesis of schizophrenia. Clin. Neuropharmacol 12: 1-13, 1989.
18. DONZANTI, B. A. AND URETSKY, N. J.: Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: Possible dependence on dopaminergic mechanisms. Neuropharmacology 22: 971-981, 1983.
19. FRENCH, E. D., PILAPIL, C. AND QUIRION, R.: Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system. Eur. J. Pharmacol. 116: 1-9, 1985.
20. FRENCH, E. D. AND VANTINI, G.: Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants. Psychopharmacology 82: 83-88, 1984.
21. GEYER, M. A., WILKINSON, L. S., HUMBY, T. AND ROBBINS, T. W.: Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol. Psychiatry 34: 361-372, 1993.
22. GRIMWOOD, S., KULAGOWSKI, J. J., MAWER, I. M., ROWLEY, M., LEESON, P. D. AND FOSTER, A. C.: Allosteric modulation of the glutamate site on the N-methyl-D-aspartate receptor by four novel glycine site antagonists. Eur. J. Pharmacol. 290: 221-226, 1995.
23. 3H]-L-689,560, an antagonist for the glycine site on the N-methyl-D-asparate receptor, to rat brain membranes. Mol. Pharmacol. 41: 923-930, 1992.
24. HAMILTON, M. H., DEBELLEROCHE, J. S., GARDINER, I. M. AND HERBERG, L. J.: Stimulatory effect of N-methyl-D-aspartate on locomotor activity and transmitter release from rat nucleus accumbens Pharmacol. Biochem. Behav. 25: 943-948, 1986.
25. HUTSON, P. H., BRISTOW, L. J., THORN, L. AND TRICKLEBANK, M. D.: R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103:2037-2044, 1991.
26. HUTSON, P. H., THORN, L., BRISTOW, L. J. AND TRICKLEBANK, M. D.: L-701,324, a glycine/NMDA receptor antagonist, attenuates activation of the mesolimbic dopamine system by phencyclidine. Br. J. Pharmacol. 114: 322P, 1995.
27. JAVITT, D. C. AND ZUKIN, S. R.: The role of excitatory amino acids in neuropsychiatric illness. J. Neuropsychiatry 2: 44-52, 1990.
28. JAVITT, D. C. AND ZUKIN, S. R.: Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148: 1301-1308, 1991.
29. JONES, G. H., HERNANDEZ, T. D., KENDALL, D. A., MARSDEN, C. A. AND ROBBINS, T. W.: Dopaminergic and serotonergic function following isolation rearing in rats: Study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol. Biochem. Behav. 43: 17-35, 1992.
30. JONES, S. M., SNELL, D. L. AND JOHNSON, K. M.: Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26: 173-179, 1987.
31. KARLER, R., CALDER, L. D., THAI, L. H. AND BEDINGFIELD, J. B.: A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 658: 8-14, 1994.
32. KELLEY, A. E AND DELFS, J. M.: Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 60: 85-95, 1994.
33. KELLEY, A. E. AND THRONE, L. C.: NMDA receptors mediate the behavioural effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29: 247-254, 1992.
34. KELLY, P. H., SEVIOUR, P. W. AND IVERSEN, S. D.: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522, 1975.
35. KREBS, M. O., KEMEL, M. L., GAUCHY, C., DESBAN, M. AND GLOWINSKI, J.: Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum. Eur. J. Pharmacol. 166: 567-570, 1989.
36. KULAGOWSKI, J. J., BAKER, R., CURTIS, N. R., LEESON, P. D., MAWER, I. M., MOSELEY, A. M., RIDGILL, M. P., ROWLEY, M., STANSFIELD, I., FOSTER, A. C., GRIMWOOD, S., HILL, R. G., KEMP, J. A., MARSHALL, G. R., SAYWELL, K. L AND TRICKLEBANK, M. D.: 3′(arylmethyl)- and 3′-(aryloxy)-3-Phenyl-4-hydroxyquinolin-2(1H)-ones: Orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem. 37: 1402-1405, 1994.
37. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238: 739-748, 1986.
38. LJUNGBERG, T. AND UNGERSTEDT, U.: Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing. Evidence for two different mechanisms of action. Psychopharmacology 56: 239-247, 1978.
39. LJUNGBERG, T. AND UNGERSTEDT, U.: A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol. Biochem. Behav. 23: 479-485, 1985.
40. LOWE, J. A., SEEGER, T. F. AND VINICK, F. J.: Atypical antipsychotics - Recent findings and new perspectives. Med. Res. Rev. 8: 475-497, 1988
41. 3H-TCP-labelled receptors in rat brain. J. Neurosci. 8: 493-501, 1988.
42. MELTZER, H. Y. AND STAHL, S. M.: The dopamine hypothesis of schizophrenia: A review. Schizophr. Bull. 2: 19-76, 1976.
43. 3H]-glutamate binding sites in rat brain. J. Neurosci. 5: 2909-2919, 1985.
44. MONYER, H., SPRENGEL, R., SCHOEPFER, R., HERB, A., HIGUCHI, M., LOMELI, H., BURNASHEV, N., SAKMANN, B. AND SEEBUBG, P. H.: Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science (Wash. DC) 256: 1217-1221, 1992.
45. MORIYOSHI, K., MASU, M., ISHII, T., SHIGEMOTO, R., MIZUNO, N. AND NAKANISHI, S.: Molecular cloning and characterization of the rat NMDA receptor. Nature (Lond.) 354: 31-37, 1991.
46. OVERTON, P. AND CLARK, D.: Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurones in the rat. Synapse 10: 131-140, 1992.
47. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982.
48. PIJNENBURG, A. J. J., HONIG, W. M. M. AND VAN ROSSUM, J. M.: Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia (Berl.) 41: 87-95, 1975.
49. PRIESTLEY, T., DANKS, P., MARSHALL, G. R, KEMP, J. A., KULAGOWSKI, J., LEESON, P. D. AND HILL, R. G.: L-701,324: A high affinity antagonist at the glycine-recognition site of the NMDA receptor. Br. J. Pharmacol. 113: 31P, 1994.
50. PULVIRENTI, L., SWERDLOW, N. R. AND KOOB, G. F.: Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40: 841-845, 1991.
51. PYCOCK, C. J. AND DAWBARN, D.: Acute motor effects of N-methyl-D-aspartic acid and kainic acid applied focally to mesencephalic dopamine cell body regions in the rat. Neurosci. Lett. 18: 85-90, 1980.
52. 3H]-dopamine from rat striatal slices. Neurosci. Lett. 96: 323-328, 1989.
53. RAO, T. S., KIM, H. S., LEHMANN, J., MARTIN, L. L. AND WOOD, P L.: Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci. 45: 1065-1072, 1989.
54. RAO, T. S., KIM, H. S., LEHMANN, J., MARTIN, L. L. AND WOOD, P. L.: Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: Tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology 29: 225-230, 1990.
55. 3H]dopamine release from rat striatum: An in vitro model for glutamate actions. J. Neurochem. 32: 1539-1545, 1979.
56. SAYWELL, K. L., BRISTOW, L. J., FOSTER, A. C., GRIMWOOD, S., HILL, R. G., HUTSON, P. H., KULAGOWSKI, J., LEESON, P. D. AND TRICKLEBANK, M. D.: The pharmacological profile of the glycine/NMDA receptor antagonist, L-701,324. Br. J. Pharmacol. 114: 320P, 1995.
57. SINGH, L., DONALD, A. E., FOSTER, A. C., HUTSON, P. H., IVERSEN, L. L., IVERSEN, S. D., KEMP, J. A., LEESON, P. D , MARSHALL, G. R., OLES, R. J., PRIESTLEY, T., THORN, L., TRICKLEBANK, M. D., VASS, C. A. AND WILLIAMS, B. J.: Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent γ-butyrolactone-like sedative. Proc. Natl. Acad. Sci. U.S.A. 87: 347-361, 1990.
58. SNELL, L. D. AND JOHNSON, K. M.: Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 238: 938-946, 1986.
59. SWERDLOW, N. R., CAINE, S. B. AND GEYER, M. A : Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 108: 189-195, 1992.
60. TANII, Y., NISHIKAWA, T , HASHIMOTO, A. AND TAKAHASHI, K.: Stereoselective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat. Brain Res. 563: 281-284, 1991.
61. TRICKLEBANK, M. D., BRISTOW, L. J. AND HUTSON, P. H.: Alternative approaches to the discovery of novel antipsychotic agents. Prog. Drug Res. 38:299-336, 1992.
62. TRICKLEBANK, M D., SINGH, L., OLES, R. J., PRESTON, C. AND IVERSEN, S. D.: The behavioural effects of MK-801: A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167: 127-135, 1989.
63. 3H]BTCP): A new phencyclidine analog selective for the dopamine uptake complex. Eur. J. Pharmacol. 148: 427-436, 1988.
64. WAN, F. J AND SWERDLOW, N. R.: Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 113: 103-109, 1993.
65. WHITE, F. J. AND WANG, R. Y.: Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science (Wash. DC) 221: 1054-1057, 1983.
66. WILLETTS, J., BALSTER, R. L. AND LEANDER, J. D.: The behavioural pharmacology of NMDA receptor antagonists, Trends Pharmacol. Sci. 11: 423-428, 1991.